Navigation Links
Leading Experts to Speak at Focused Ultrasound Symposium
Date:6/25/2010

nt of Radiation Oncology, Dana-Farber/Brigham & Women's Cancer, Center, Harvard Medical School, Boston
  • Ferenc Jolesz, M.D., National Center for Image-Guided Therapy, Brigham & Women's Hospital, Boston
  • Neal Kassell, M.D., Department of Neurosurgery, University of Virginia, Charlottesville
  • Laurence Klotz, M.D., Sunnybrook Health Sciences Centre, Toronto
  • King Li, M.D., M.B.A., The Methodist Hospital Research Institute, Houston
  • Matthias Matzko, M.D., Amper Kliniken, AG, Dachau
  • Elliot McVeigh, Ph.D., Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore
  • Chrit Moonen, Ph.D., Imagerie Moleculaire et Fonctionnelle: de la Physiologie a la Therapie, University Victor Segalen, Bordeaux
  • Dennis Parker, Ph.D., Utah Center for Advanced Imaging Research, Departments of Bioengineering & Radiology, University of Utah, Salt Lake City
  • Raphael Pfeffer, M.D., Department of Radiation Oncology, Chaim Sheba Medical Center, Tel Hashomer
  • Joy Polefrone, Ph.D., Focused Ultrasound Surgery Foundation, Charlottesville
  • Mitchell Schnall, M.D., Department of Radiology, University of Pennsylvania, '/>"/>

  • SOURCE Focused Ultrasound Surgery Foundation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
    2. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
    3. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
    4. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
    5. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
    6. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
    7. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection
    8. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
    9. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
    10. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
    11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2015)... WAYNE, Pa. , July 31, 2015 /PRNewswire/ ... a fully integrated specialty pharmaceutical company focused on ... announced the closing of its previously announced underwritten ... stock at a public offering price of $11.25 ... the offering included 1,000,000 shares issued upon the ...
    (Date:7/31/2015)... , July 31, 2015 ... for video, data and cloud computing operators has ... leading pharma giant for Internet of Things (IoT) ... applications offered on subscription model.      ... giant is striving for business innovations to make ...
    (Date:7/30/2015)... (NYSE: RMD ) today announced results for its ... was $453.1 million, a 9 percent increase compared with ... increase on a constant currency basis).  Net income was ... 2014.  Diluted earnings per share for the quarter were ... The results for the quarter ended ...
    Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16
    ... SAN DIEGO, Oct. 18, 2011 Halozyme Therapeutics, ... company developing and commercializing products targeting the ... and drug delivery markets, today announced that the ... that women with HER2-positive early breast cancer who ...
    ... Oct. 17, 2011 Express Scripts (Nasdaq: ESRX ... North America, announced today its intention to release its third ... closes and will hold its quarterly conference call to discuss ... a.m. Eastern Time (8:30 a.m. Central Time). This ...
    Cached Medicine Technology:Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial 2Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial 3Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial 4
    (Date:8/1/2015)... ... August 01, 2015 , ... Brig and Lita Hart, icons of the network ... their Healthy Home mission with the HOPE Movement of EvolvHealth. In what has been ... companies have agreed to join their missions of purpose together to change the course ...
    (Date:8/1/2015)... ... August 01, 2015 , ... BeverlyD, owner and founder of ... making hers the very first small business donation to kick off the campaign for ... thirty years. Her legacy includes a complete line of raw, organic hair care products, ...
    (Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reputable source of authentic tickets ... Garden Arena. Fans of every genre of music will have an act they are ... day of the festival, the following artists will perform: Sam Smith, Coldplay, Kenny Chesney, ...
    (Date:7/31/2015)... ... 31, 2015 , ... Ticket Down is a reliable source for authentic tickets ... Grant Park. The festival will end on Sunday, August 2nd. , ... annual Lollapalooza. This unique and unbelievably popular festival attracts the best in entertainment ...
    (Date:7/31/2015)... Memphis, Tenn. (PRWEB) , ... July 31, 2015 , ... ... at Robert Church Park in Downtown Memphis on October 3, 2015. The Ride to ... partnership focused on cancer research between Methodist Healthcare, The West Clinic and The University ...
    Breaking Medicine News(10 mins):Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:March4thforWellBeing Foundation Kickoff 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 3Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3
    ... a study testing a vaginal microbicide with an antiretroviral (ARV) ... was significantly more protective against HIV infection than a placebo ... the study, known as CAPRISA 004, are to be reported ... published online by the journal Science . ...
    ... N.C. Monday, July 19, 2010 Kidney disease ... a million individuals in the United States requiring dialysis ... The problem is particularly acute among African-Americans, whose rates ... of European Americans. As reported online this month ...
    ... Cancer researchers have discovered a previously unknown type ... cells that may lead to better insight about environmental ... in the journal Genome Research by researchers ... James Cancer Hospital and Richard J. Solove Research Institute ...
    ... sex offenders are often stereotyped and treated as socially ... they are more likely to be characterized by atypical ... coercive sex with peers and adults, and exposing their ... likely to have a history of sexual abuse themselves, ...
    ... HealthDay Reporter , MONDAY, July 19 (HealthDay ... illicit "club drug" Ecstasy may have one positive use: ... disorder (PTSD). The drug, also known by its ... standard treatments have failed. But experts stressed that ...
    ... July 2010 [Vienna, Austria]Scientists, practitioners and advocates from around ... leaders to commit at least $US20 billion to the ... its upcoming replenishment meeting in October. Because the level ... Global Fund,s grant levels for 2011-2013, the meeting is ...
    Cached Medicine News:Health News:Microbicide trial results a turning point for HIV prevention, says team testing same gel 2Health News:Microbicide trial results a turning point for HIV prevention, says team testing same gel 3Health News:Investigators identify gene associated with kidney disease in African-American population 2Health News:Investigators identify gene associated with kidney disease in African-American population 3Health News:Breast cancer cells regulate multiple genes in response to estrogen-like compounds 2Health News:New study challenges stereotypes of adolescent sex offenders 2Health News:New study challenges stereotypes of adolescent sex offenders 3Health News:Researchers Use Ecstasy to Treat PTSD 2Health News:Researchers Use Ecstasy to Treat PTSD 3Health News:AIDS 2010 delegates and speakers unite in support of full funding for the Global Fund, the next milestone in drive for universal access 2Health News:AIDS 2010 delegates and speakers unite in support of full funding for the Global Fund, the next milestone in drive for universal access 3Health News:AIDS 2010 delegates and speakers unite in support of full funding for the Global Fund, the next milestone in drive for universal access 4
    ... 1991 Intersurgical Incorporated manufactures ... heat and moisture exchangers, ... products, hand-held nebulizers and ... accessories and connectors for ...
    ... product line has the right product for ... and from intubated patients to patients with ... both anesthesia and critical care applications., ... protection for patients and staff members. This ...
    ... Since 1991 Intersurgical Incorporated ... filters, heat and moisture ... therapy products, hand-held nebulizers ... of accessories and connectors ...
    ... Intersurgical Incorporated manufactures high ... and moisture exchangers, ventilator ... hand-held nebulizers and an ... and connectors for anesthesia ...
    Medicine Products: